• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cyclo Therapeutics Inc (NQ: CYTH )

    0.7276 +0.0176 (+2.48%)
    Streaming Delayed Price Updated: 12:49 PM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cyclo Therapeutics Inc

    < Previous 1 2 3 4 5 6 Next >
    Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. 
    Via Benzinga
    Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
    Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results. Bridgeline Digital posted a narrower-than-expected loss for its fourth... 
    Via Benzinga
    Topics Earnings
    Exposures Financial
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
    Company remains focused on generating shareholder value by advancing our portfolio and identifying attractive opportunities for strategic investments 
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
    Company positions itself to generate value for its stockholders by curtailing expenses while increasing investment in strategic opportunities 
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics to Present at 8th Annual Dawson James Conference
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq – NXGN), Computer Task Group, Incorporated (Nasdaq -
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. 
    Via Benzinga
    Rare Disease Player Cyclo Therapeutics To Merge With Applied Molecular Transport
    Applied Molecular Transport Inc (NASDAQ: AMTI) has agreed to merge with Cyclo Therapeutics Inc (NASDAQ: CYTH) in an  
    Via Benzinga
    CYTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Cyclo Therapeutics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Cyclo Therapeutics And This Other Penny Stock Insiders Are Buying
    The Dow Jones closed lower by around 350 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Publication of Positive Data from Phase 2 Clinical Study of Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Why Inventiva Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket
    Gainers Cyxtera Technologies, Inc. (NASDAQ: CYXT) shares rose 134.6% to $0.0981 in pre-market trading after dropping 12% on Tuesday. 
    Via Benzinga
    Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
    Since the end of the third quarter, we made an initial $2.1 million investment in Cyclo Therapeutics, Inc. (Nasdaq: CYTH) and have an agreement to increase our investment by $5 million 
    From Rafael Holdings, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.